GSK-207573

Study Sponsor: GSK

Study Title

A Two Part, Randomized, Open-label, Cross over Study in Healthy Elderly Participants to Evaluate the Relative Bioavailability of Hydrobromide Salt Tablet Formulations of Danirixin in the Fed and Fasted States, and to Evaluate the Effect of Food and Gastric Acid Secretion Suppression on Danirixin Pharmacokinetics Following Administration of Hydrobromide Salt Tablets

Medicine or Vaccine (generic name)

danirixin

Sponsor Identification Number

207573

Trial Registry Identification Number(#'s)

NCT03457727

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=207573

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03457727

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

March 2021